Bayer buys glaucoma drugmaker in 2.45 bln-dollar deal
Frankfurt – German agrichemical and pharmaceutical giant Bayer said Wednesday it would buy experimental glaucoma drug maker Perfuse Therapeutics... Read more
6 May
